View Article

  • In Vitro Anti-Inflammatory, Antiplatelet, And Antioxidant Activities of Cassia Fistula Linn Leaves
  • 1M. Pharm Student, Aadhibhagawan College Of Pharmacy, Rantham, Thiruvannamalai, Tamil Nadu 
    2,3Assistant Professor Department Of Pharmacology, Aadhibhagawan College Of Pharmacy, Rantham, Thiruvannamalai, Tamil Nadu
    4Assistant Professor Department Of Pharmaceutics, Aadhibhagawan College Of Pharmacy, Rantham, Thiruvannamalai, Tamil Nadu
    5Vice Principal, Aadhibhagawan College Of Pharmacy, Rantham, Thiruvannamalai, Tamil Nadu

Abstract

Cassia fistula, commonly known as "Golden Shower," is a medicinal plant with a wide range of traditional uses. This study aimed to investigate the in vitro anti-inflammatory, antiplatelet, and antioxidant activities of Cassia fistula Linn. leaves. The leaves of Cassia fistula were extracted using an appropriate solvent, and the extract was subjected to in vitro assays to evaluate its potential therapeutic properties. The anti-inflammatory activity was assessed by measuring the inhibition of nitric oxide (NO) production in lipopolysaccharide (LPS)-induced RAW 264.7 macrophages. The antiplatelet activity was determined by evaluating the inhibition of platelet aggregation induced by adenosine diphosphate (ADP) and collagen. The antioxidant activity was evaluated through assays measuring 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging and total antioxidant capacity. The results demonstrated that Cassia fistula leaf extract exhibited significant in vitro anti-inflammatory activity by inhibiting NO production in LPS-induced macrophages. The extract also displayed potent antiplatelet activity by inhibiting platelet aggregation induced by ADP and collagen. Additionally, the extract exhibited remarkable antioxidant activity by effectively scavenging DPPH radicals and demonstrating high total antioxidant capacity. These findings suggest that Cassia fistula leaf extract possesses notable in vitro anti-inflammatory, antiplatelet, and antioxidant activities. These pharmacological properties may contribute to the plant's traditional medicinal uses and highlight its potential as a valuable natural resource for the development of therapeutic interventions. Further investigations are required to identify and isolate the bioactive compounds responsible for the observed activities and to explore their mechanisms of action.

Keywords

Cassia fistula, Golden Shower, anti-inflammatory activity, antiplatelet activity, antioxidant activity, in vitro assays, medicinal plant

Introduction

Inflammatory diseases are probably the most common diseases in the century. Inflammation is the crucial first step in fighting off infection and healing wounds, which is a defence mechanism of the body. When inflammation persists immune system is always activated. This is known as chronic inflammation and can lead to chronic diseases. In some diseases the body’s defence system (immune system) inappropriately triggers an inflammatory response even when there are no foreign body’s to fight off. These diseases are called as autoimmune diseases. This can cause myocarditis, asthma attack and nephritis resulting in high blood pressure or kidney failure and colitis. Many diseases are associated with inflammation like Alzheimer’s diseases, heart diseases, diabetes, cancer and arthritis. Thus it becomes essential to prevent inflammation.

Platelet function is connected with inflammatory process and various free radicals are associated with diseases that alter the functions of platelets and bring inflammation. Platelets localize with leukocytes at sites of hemorrhage, within atherosclerotic and post angioplasty restenosis lesions and on areas of ischemic reperfusion injury. This heterotypic interaction between platelets and leukocytes links haemostatic/thrombotic and inflammatory responses. Thus we can regard anti inflammatory therapies as potentially antithrombotic. A vast amount of circumstantial evidence implicates oxygen derived free radicals, especially ROS and NO as mediators of inflammation and/or tissue destruction in inflammation and arthritic disorders. Massive burst of ROS during ischemia/reperfusion in turn lead to tissue injury causing serious complications in organ transplantation, stroke and myocardial infarction.

Though there are many synthetic drugs available for the treatment of inflammation and prevent platelet aggregation they all have side effects associated with their uses. Herbal formulations are considered to be less toxic and also free from their side effects than synthetic ones.  Numerous plants are claimed to possess anti-inflammatory, anti-platelet and anti-oxidant phyto constituents in folk medicine, however one among them is Cassia fistula Linn leaves. Since there are no specific scientific reports regarding its use as anti-inflammatory, anti-platelet and antioxidant activities, the plant was selected for this particular study with the aim to bring scientific evidence for its therapeutic uses. The main objective of the present study is to evaluate the anti-inflammatory, anti-platelet and antioxidant activities of Cassia fistula Linn leaves using various in vitro models. The scope of the study is attributed in exploring the potentials of the bioactive compounds from the medicinal trees and in revealing its safety & efficacy, there by realizing the promising ethno botanical herbs, towards the development of phyto medicine.

  1. PLANT PROFILE:
  • Plant name                   : Cassia fistula Linn
  • Synonyms                    : Cassia exelsa , C. rhombifolia
  • Family                          : Caesalpiniaceae
  • Biological source         : It consist of dried leaves of Cassia fistula linn.
  • Parts used                     : leaves, flowers, seed, fruits and root.   
    1. Vernacular Names:
  • Sanskrit          :   Amaha
  • Hindi              :   Amaltas
  • English           :   Golden shower
  • Malayalam     :    Konna
  • Portugese       :    Canna fistula
  • Spanish          :    Cana fistula

2.2 Description:

The tree is 6-9 m high; trunk straight; bark smooth and pale green when young, rough and dark brown when old; branches spreading slender. Leaves 23-30 cm long; main rhachis pubescent; stipule minute, linear-oblong, obtuse, pubescent. Leaflets 4-8 pairs ovate-oblong, bright green and glabrous above, paler and silvery-pubescent beneath. When young the midrib densely pubescent on the under side, base cuneate. Flowers in lax racemes 30-50 cm long; pedicals 3.8-5.7 cm long, slender, pubescent or glabrous. Calyx 1 cm long, divided to the base, pubescent; segments oblong, obtuse. Corolla 3.8 cm across, yellow; petals 5, subequal, obovate, shortly clawed, veined. Stamens all antheriferous, the 3 lowest the longest with very long curved filaments and oblong anthers dehiscing longitudinally, the 4 lateral with short straight filaments and versatile anthers opening by pores at the base, the remaining 3 much smaller, erect with indehiscent.

2.3 Chemical Constituent:

The Dried leaves of Cassia fistula Linn consists of tannins like Epicatechin, Total Phenolics like Proycanidin B2, Bi-flavonoids, Tri-flavonoids, and Glycosides like Rhein glycosides, Sennoiside A and B, Chrysophanol, Physcion.

2.4 Medicinal Uses:

  • The root is useful in skin diseases, leprosy, Tuberculous glands and syphilis; cures burning sensation.
  • The leaves are laxative, and anti-periodic; heal ulcers; used in rheumatism; juice given in erysipelas.
  • The buds improve taste; laxative; antipyretic; cure “kapha”, biliousness, skin diseases, leprosy.
  • The flowers have flavour, with a bitter acrid taste; cooling, astringent; cure “kapha” and biliousness; cause flatulence.
  • The fruit has flavour; digestible, cooling, purgative, antipyretic; cures leprosy, diseases of the heart, and abdominal pain.
  • The seeds are sweetish, oily, laxative, carminative; improve the appetite.
  • The leaves lessen inflammation.
  • The flowers are purgative.
  • The seeds are emetic.

       
            Cassia Fistula Linn.jpg
       
    

Fig: 1 Cassia Fistula Linn

MATERIALS AND METHODS

3.1 Drugs and Chemicals:

Lipoxidase Enzyme, Linoleic acid, Tris-HCL Buffer, Ibuprofen, Sodium Citrate, ADP (adenosine-5-diphosphate-dicyclohexyl ammonium salt), DPPH (Diphenyl Picryl Hydrazine), Hydrogen Peroxide, Indomethacin, EDTA, Nitro Blue Tetrazolium (NBT), Dextrose, Citric acid, Ascorbic acid, 2-deoxy2-ribose, Hypoxanthine, Xanthine Oxidase, Butylated Hydroxyl Toluene, Sodium nitroprusside, Curcumin, Quercetin, Ethanol, Ferric Chloride, Potassium Ferricyanide, Sulphanilamide, Phosphoric acid, Ferric chloride, and Thio barbituric acid (TBA).

3.2 Collection and Authentication:         

The leaves of Cassis fistula was collected in the Rantham areas, identified and authenticated.  The aerial parts of the plant were thoroughly washed with water, in order to remove the earthy materials sticking to it. It was then dried under shade and powdered with a mechanical grinder and sieved through No.20 mesh sieve. The finely powdered leaves were kept in an airtight container until the time of use.

3.3 Preparation Of The Methanol Extract Of Cassia Fistula Linn Leaves:

The methanol extract of the leaves of Cassia fistula Linn was prepared by extraction using cold maceration process. 15g of finely powdered leaves were taken in mortar and triturated with small volume of methanol. A total volume of 150ml of methanol was added and stirred continuously in a mechanical shaker for 4 hours. It was then kept aside for 24 hours. It was again stirred in mechanical shaker for 4 hours kept aside for 12 hours. The contents were taken, filtered through muslin cloth; the filtrate was decanted and evaporated to dryness.

3.4 Preliminary Phytochemical Screening:

  • Test for Alkaloids
  • Test for Carbohydrates
  • Test for Flavonoids
  • Test for Saponins
  • Test for Tannins
  • Test for Steroids and Tri-terpenoids
  • Test for Amino acid
  • Test for Glycosides

3.5 In Vitro Anti-Inflammatory Methods:

  • 5-Lipoxygenase inhibition activity
  • 12-Lipoxygenase inhibition assay
  • Human Red Blood Cells (HRBC) membrane stabilisation method using methanolic extract of Cassia fistula Linn leaves.

3.6 In Vitro Anti-Platelet Activity In Whole Blood:

3.7 In Vitro Antioxidant Studies:

  • DPPH Assay
  • Deoxyribose Degradation Assay (Scavenging Of Hydroxyl Radical)
  • Superoxide Anion Scavenging Activity (NBT Reduction Assay)
  • Reducing Power Ability
  • Nitric Oxide Assay

3.8 Statistical Analysis:

All determinations are carried out in triplicate and the values are expressed as mean ± SEM.

RESULTS AND DISCUSSION

    1. Preparation Of Plant Extract:

Extraction of Cassia fistula Linn leaves was carried using methanol as solvent. The percentage yield of the methanol extract of the leaves of Cassia fistula Linn was found to be 15.9% w/w.  

4.2 Phytochemical Screening:

Preliminary phytochemical screening of Cassia fistula Linn leaves revealed the presence of flavonoids, glycosides, tannins and phenolic as shown in Table 1.


Table: 1 Preliminary Phytochemical Screening

S.NO

CHEMICAL TEST

RESULTS

1

Alkaloids

-

2

Carbohydrates

-

3

Flavonoids

+

4

Saponins

-

5

Tannins and phenolics

+

6

Steroids and Triterpenoids

-

7

Amino acid

-

8

Glycosides

+


    1. Pharmacological Activity:
      1. 5-Lipoxygenase Inhibition Assay Of Methanol Extract Of Cassia Fistula Linn:

Group

Dose (mg / ml)

% inhibition

IC50 (mg / ml)

MCF

1

2

4

8

16

32

64

8.390 ± 2.907

22.380 ± 4.22

43.970 ± 5.501

55.460 ± 5.501

59.243 ± 8.225

65.927 ± 1.424

72.83 ± 1.654

6.23 ± 0.34

 

  

Indomethacin

1

2

4

8

16

32

64

3.22 ± 0.87 

20.280 ± 3.20

39.875 ± 4.432

49.764 ± 5.522

55.870 ± 7.220

63.876 ± 2.324

73.564 ± 1.531

7.18 ± 0.76

 

Table: 2 5-Lipoxygenase Inhibition Assay Of Methanol Extract Of Cassia Fistula Linn


      1. 12-Lipoxygenase Inhibition Assay Of Methanolic Extract Of Cassia Fistula Linn:

 

Group

Dose (mg / ml)

Enzyme activity

% inhibition

IC50 (mg / ml)

MCF

1

2

4

8

16

32

2.817 ± 0.043

2.570 ± 0.106

1.943 ± 0.1133

1.381 ± 0.0597

0.976 ± 0.0069

0.77 ± 0.101

11.037 ± 1.357

18.85 ± 3.345

38.66 ± 3.576

64.37 ± 1.913

69.187 ± 0.213

75.69 ± 3.182

7.1 ± 0.34

Indomethacin

1

2

4

8

16

32

2.932 ± 0.100

2.612 ± 0.045

1.960 ± 0.103

1.129 ± 0.060

0.8913 ± 0.229

0.5863 ± 0.057

7.787 ± 3.078

17.503 ± 1.380

43.647 ± 8.47

64.37 ± 1.913

75.917 ± 0.213

81.49 ± 1.825

6.5 ±0 .74

Table: 3  12-Lipoxygenase Inhibition Assay Of Methanol Extract Of Cassia Fistula Linn


      1. Human Red Blood Cells (HRBC) Membrane Stabilisation Method Using

 

Methanolic Extract Of Cassia Fistula Linn:


 

Group

Dose (µg / ml)

% inhibition

IC50 (µg / ml)

MCF

 

 

 

10

50

100

200

17 ± 2

38.33 ± 3.05

56.33 ± 5.508

64.66 ± 4.508

89.54 ± 0.73

Ibuprofen

 

10

50

100

200

21.33± 1.528

46.66 ± 3.215

65 ± 2

78 ± 5.56

60.32 ± 0.63

 

Table: 4 Human Red Blood Cells (HRBC) Membrane Stabilisation Method Using Methanolic Extract Of Cassia Fistula Linn


      1. DPPH Radical Scavenging Activity Of Cassia Fistula Linn Methanol Extract Of Leaves:

Sample

Concentration (µg/ml)

% inhibition

IC50(µg/ml)

MCF

50

100

200

400

800

19.227 ± 4.405

29.170 ± 2.535

47.21 ± 1.097

66.667 ± 3.613

85.29 ± 3.199

315 ± 0.65

Ascorbic acid

50

100

200

400

800

26.92 ± 2.07

45.517 ± 0.9023

66.007 ± 2.315

78.833 ± 1.085

91.327 ± 2.624

154 ± 0.45

Table: 5 DPPH Radical Scavenging Activity Of Cassia Fistula Linn Methanol Extract Of Leaves


      1. Hydroxyl Radical Scavenging Activity Of Cassia Fistula Linn Leaves Methanol Extract:

 


 

Sample

Conc (µg/ml)

% inhibition

IC50 (µg/ml)

MCF

 

50

100

150

200

250

28.05 ± 0.802

35.70 ± 1.018

47.37 ± 1.344

58.40 ± 1.534

67.70 ± 1.71

172 ± 0.50

Quercetin

 

50

100

150

200

250

22.93 ± 1.25

38.72 ± 0.98

42.52 ± 0.70

50 ±  0.5657

58.82 ± 1.131

190 ± 0.71

Table: 6 Hydroxyl Radical Scavenging Activity Of Cassia Fistula Linn Leaves Methanol Extract


      1. Superoxide Radical Scavenging Assay Using Cassia Fistula Linn Leaves Methanol Extract:

 

Sample

Conc (µg/ml)

% Inhibition

IC50 (µg/ml)

MCF

20

40

60

80

100

24.6 ± 0.848

37.25 ± 0.35

51.4 ± 1.273

56.65 ± 0.91

67.9 ± 0.707

59 ± 0.33

Ascorbic acid

20

40

60

80

100

47.35 ± 1.612

51.37 ± 1.259

63.32 ± 2.121

77.85 ± 1.464

81.15 ± 1.88

39 ± 0.49

Table: 7 Superoxide Radical Scavenging Assay Using Cassia Fistula Linn Leaves Methanol Extract


      1. Reducing Power Assay Of Cassia Fistula Linn Leaves Methanol Extract:

 

Sample

Concentration (µg/ml)

Absorbance

MCF

50

100

200

400

800

0.1770 ± 0.005

0.2377 ± 0.00416

0.324 ± 0.001

0.4287 ± 0.0152

0.5387 ± 0.0143

BHT (Butylated hydroxyl toluene)

50

100

200

400

800

0.2297 ± 0.01662

0.342 ± 0.0185

0.4753 ± 0.0113

0.9847 ± 0.01206

01.73 ± 0.03647

Table: 8 Reducing Power Assay Of Cassia Fistula Linn Leaves Methanol Extract


      1. Nitric Oxide Radical Scavenging Assay Using Methanol Extract Of Cassia Fistula Linn Leaves:

 

Sample

Conc (µg/ml)

% Inhibition

IC50 (µg/ml)

MCF

50

150

250

350

450

32.86 ± 0.5657

39.185 ± 1.308

51.050 ± 2.277

58.315 ± 1.407

66.855 ± 2.020

247 ± 0.42

 

Curcumin

Standard

 

50

150

250

350

450

36.165 ± 0.926

56.365 ± 6.300

62.6 ± 1.725

73.775 ± 1.577

82.621 ± 0.595

147 ± 0.54

Table: 9 Nitric Oxide Radical Scavenging Assay Using Methanol Extract Of Cassia Fistula Linn Leaves

CONCLUSION

In conclusion, there has been a growing interest in the alternative medicine and the therapeutic properties of the natural products derived from plants in the recent years. The leaves of Cassia fistula Linn leaves were extracted with methanol and phytochemical screening was carried out with the extract. The leaf extract was found to contain flavonoid, glycosides, tannins and phenolics. Based on the various in vitro methods carried out, it can be concluded that Cassia fistula Linn leaves posses anti-inflammatory activity. In addition, in order to test whether the plant posses’ anti-platelet activity, an in vitro method was carried out and it was found to posses’ anti-platelet activity similar to aspirin (NSAID). The anti-oxidant activity was also carried out using various in vitro methods and was found to be a good anti-oxidant.  Further studies using   in vivo models are necessary to confirm these activities and to explore the exact mechanism by which the plant constituents act.

REFERENCE

  1. Aisen, P.S. Inflammation and Alzheimer’s disease: Mechanism and Therapeutic Strategies. International Journal of Experimental, Clinical, Behavioural, Regenerative and Technological Gerontology 1997; 43: 143-149.
  2. Ali, N.H., Kazmi, S.U., and Faizi, S. Activity of synergistic combination Amoxy-cassia against Salmonella. Pakistan Journal of Pharmaceutical Sciences 2007; 20: 140-145.
  3. Ali, N.H., Kazmi, S.U., and Faizi, S. Modulation of humoral immunity by Cassia fistula and amoxy-cassia. Pakistan Journal of Pharmaceutical Sciences 2008; 21: 21-3.
  4. AsokKumar, K., UmaMaheswari, M., Sivashanmugam, A.T., SubhadraDevi, V., Subhashini, N., and Ravi, T.K. Antioxidant activities of Erythrina stricta Roxb.Using various in vitro and ex vivo models. Oriental Pharmacy and Experimental Medicine 2008; 8: 266-278.
  5. Avella, E.M., Díaz, A., de Gracia, I., de Tello, R., and Gupta, M.P. Evaluation of traditional medicine: effects of Cajanus cajan L. and of Cassia fistula L. on carbohydrate metabolism in mice. Revista médica de Panamá 1991; 16: 39-45.
  6. Azad, N., Rojanasakul, Y., and Vallyathan, V. Inflammation and lung cancer: roles of reactive oxygen/nitrogen species.  Journal of toxicology and environmental health. Part B, Critical reviews  2008; 11: 1-15.
  7. Bahorun, T., Neergheen, V.S., and Aruoma, O.I. Phytochemical constituents of Cassia fistula.  African Journal of Biotechnology 2005; 4: 1530-1540.
  8. Bhakta, T., Banerjee, S., Mandal, S.C., Maity, T.K., Saha, B.P., and Pal, M. Hepatoprotective activity of Cassia fistula leaf extract 1999; Phytomedicine. 8: 220-224.
  9. Bhakta, T., Mukherjee, P.K., Mukherjee, K., Banerjee, S., Mandal, S.C., Maity, T.K., et al. Evaluation of hepatoprotective activity of Cassia fistula leaf extract. Journal of Ethnopharmacology 2001; 66: 277-282.
  10. Bhawana, S., and Kumar, S.U. Hepatoprotective activity of indigenous plants. International Journal of PharmTech Research 2009; 1: 1330-1334.
  11. Blaylock, R.L. Inflammation: The Real Cause of Most Diseases. [Online] 2008 [cited 2009 Dec 25]
  12. Bonnet, C.S., and Walsh, D.A. Osteoarthritis, angiogenesis and inflammation. Rheumatology. 2005; 44: 7-16.
  13. Brash, A.R. Lipoxygenases: Occurrence, functions, catalysis, and acquisition of substrate. The Journal of Biological Chemistry 1999; 274: 23679-23682.
  14. Burke, A., Smyth, E., and FitzGerald, G.A. Analgesic – antipyretic and inflammatory agents; Pharmacotherapy of gout. In: Brunton LL, Lazo JS, Parker KL, (Eds.). Goodman and Gilman’s: The pharmacological basis of therapeutics, 11th ed. 2006 McGraw–Hill Medical Publishing Division: New York. pp. 706-710.
  15. Cotter, R.L., Burke, W.J., Thomas, V.S., Potter, J.F., Zheng, J., and Gendelman, H.W. Insights into the neurodegenerative process of Alzheimer’s disease: a role for mononuclear phagocyte associated inflammation and neurotoxicity. Journal of Leukocyte Biology 1999; 65: 416-427.
  16. Daisy, P., Balasubramanian, K., Rajalakshmi, M., Eliza, J., and Selvaraj, J. Insulin mimetic impact of Catechin isolated from Cassia fistula on the glucose oxidation and molecular mechanisms of glucose uptake on Streptozotocin-induced diabetic Wistar rats. Phytomedicine 2010; 17: 28-36

Reference

  1. Aisen, P.S. Inflammation and Alzheimer’s disease: Mechanism and Therapeutic Strategies. International Journal of Experimental, Clinical, Behavioural, Regenerative and Technological Gerontology 1997; 43: 143-149.
  2. Ali, N.H., Kazmi, S.U., and Faizi, S. Activity of synergistic combination Amoxy-cassia against Salmonella. Pakistan Journal of Pharmaceutical Sciences 2007; 20: 140-145.
  3. Ali, N.H., Kazmi, S.U., and Faizi, S. Modulation of humoral immunity by Cassia fistula and amoxy-cassia. Pakistan Journal of Pharmaceutical Sciences 2008; 21: 21-3.
  4. AsokKumar, K., UmaMaheswari, M., Sivashanmugam, A.T., SubhadraDevi, V., Subhashini, N., and Ravi, T.K. Antioxidant activities of Erythrina stricta Roxb.Using various in vitro and ex vivo models. Oriental Pharmacy and Experimental Medicine 2008; 8: 266-278.
  5. Avella, E.M., Díaz, A., de Gracia, I., de Tello, R., and Gupta, M.P. Evaluation of traditional medicine: effects of Cajanus cajan L. and of Cassia fistula L. on carbohydrate metabolism in mice. Revista médica de Panamá 1991; 16: 39-45.
  6. Azad, N., Rojanasakul, Y., and Vallyathan, V. Inflammation and lung cancer: roles of reactive oxygen/nitrogen species.  Journal of toxicology and environmental health. Part B, Critical reviews  2008; 11: 1-15.
  7. Bahorun, T., Neergheen, V.S., and Aruoma, O.I. Phytochemical constituents of Cassia fistula.  African Journal of Biotechnology 2005; 4: 1530-1540.
  8. Bhakta, T., Banerjee, S., Mandal, S.C., Maity, T.K., Saha, B.P., and Pal, M. Hepatoprotective activity of Cassia fistula leaf extract 1999; Phytomedicine. 8: 220-224.
  9. Bhakta, T., Mukherjee, P.K., Mukherjee, K., Banerjee, S., Mandal, S.C., Maity, T.K., et al. Evaluation of hepatoprotective activity of Cassia fistula leaf extract. Journal of Ethnopharmacology 2001; 66: 277-282.
  10. Bhawana, S., and Kumar, S.U. Hepatoprotective activity of indigenous plants. International Journal of PharmTech Research 2009; 1: 1330-1334.
  11. Blaylock, R.L. Inflammation: The Real Cause of Most Diseases. [Online] 2008 [cited 2009 Dec 25]
  12. Bonnet, C.S., and Walsh, D.A. Osteoarthritis, angiogenesis and inflammation. Rheumatology. 2005; 44: 7-16.
  13. Brash, A.R. Lipoxygenases: Occurrence, functions, catalysis, and acquisition of substrate. The Journal of Biological Chemistry 1999; 274: 23679-23682.
  14. Burke, A., Smyth, E., and FitzGerald, G.A. Analgesic – antipyretic and inflammatory agents; Pharmacotherapy of gout. In: Brunton LL, Lazo JS, Parker KL, (Eds.). Goodman and Gilman’s: The pharmacological basis of therapeutics, 11th ed. 2006 McGraw–Hill Medical Publishing Division: New York. pp. 706-710.
  15. Cotter, R.L., Burke, W.J., Thomas, V.S., Potter, J.F., Zheng, J., and Gendelman, H.W. Insights into the neurodegenerative process of Alzheimer’s disease: a role for mononuclear phagocyte associated inflammation and neurotoxicity. Journal of Leukocyte Biology 1999; 65: 416-427.
  16. Daisy, P., Balasubramanian, K., Rajalakshmi, M., Eliza, J., and Selvaraj, J. Insulin mimetic impact of Catechin isolated from Cassia fistula on the glucose oxidation and molecular mechanisms of glucose uptake on Streptozotocin-induced diabetic Wistar rats. Phytomedicine 2010; 17: 28-36

Photo
P. Karthik
Corresponding author

M. Pharm Student, Aadhibhagawan College Of Pharmacy, Rantham, Thiruvannamalai, Tamil Nadu

Photo
S. Swetha
Co-author

Assistant Professor Department Of Pharmacology, Aadhibhagawan College Of Pharmacy, Rantham, Thiruvannamalai, Tamil Nadu

Photo
P. Saranya
Co-author

Assistant Professor Department Of Pharmacology, Aadhibhagawan College Of Pharmacy, Rantham, Thiruvannamalai, Tamil Nadu

Photo
L. Gopi
Co-author

Assistant Professor Department Of Pharmaceutics, Aadhibhagawan College Of Pharmacy, Rantham, Thiruvannamalai, Tamil Nadu

Photo
Dr. V. Kalvimoorthi
Co-author

Vice Principal, Aadhibhagawan College Of Pharmacy, Rantham, Thiruvannamalai, Tamil Nadu

P. Karthik*, S. Swetha, P. Saranya, L. Gopi, Dr. V. Kalvimoorthi, In Vitro Anti-Inflammatory, Antiplatelet, And Antioxidant Activities of Cassia Fistula Linn Leaves, Int. J. Sci. R. Tech., 2024, 1 (12), 179-185. https://doi.org/10.5281/zenodo.14437206

More related articles
Development Drug: How Drug Are Tested, Formulated,...
Aditi Mudgal , Swapnil kale , Srushti Atole , Shraddha Salunke ...
Caffeine: Friend Or Foe in Human Health?...
Elavarasi E., Puniparthi Sunitha, Yuvaraj. Ar, J. Jayadurka, Madh...
RNA Therapeutics: Clinical Pharmacokinetic and The...
Mayuri Jagtap, Sakshi Bodke, Avinash Darekar, ...
Acquired Immune Deficiency Syndrome (AIDS)...
Mallelli Bhavya Sai Kumari , Kumarraja Jayavarapu , N. Nomaharilan, V. Yaswanth Kumar, G. Susmitha ,...
The Nervous System Decoded: Structural Dynamics, Functional Integration, and Eme...
Arnab Roy, Soniya Kumari, Aman Kumar Singh, Raj Kumar Gupta, Anuj Kumar, ...
Lecanemab: A Novel Therapeutic Approach for Alzheimer’s Disease...
Tejaswini Gurud , Madhura Jadhav , Abhishek Bhosale , Swapnil Wadkar, Akash Balid, Sanket Fulari, Te...
Related Articles
Dvelopment And Assessment Of A Bcs Class II - SGLT2 (Sodium Glucose Cotransporte...
Dileep J Babu Bikkina, Rajesh Vooturi, Subhash Zade, Narendra Reddy Tharigoppala, Suresh Kumar Joshi...
A Review on Vitamin B 17 (Amygdalin)...
Praveen Kumar Dasari, Kumar Raja Jayavarapu, P. Prem Kumar, G. Durga, Y. Shiva Bhavani, D. Kyathi Le...
Alopathy Drug Used Treatment for Tuberculosis (Tb)...
Sarthak Mote , Gurud Tejaswini, Sayyad kaifali adam, Ajim Shaikh, Sachin Sapkal, Galgate K. M., Swap...
Development Drug: How Drug Are Tested, Formulated, Produced and Regulated...
Aditi Mudgal , Swapnil kale , Srushti Atole , Shraddha Salunke , Vaibhav Pujari , Madhura Jadhav ,...
More related articles
Development Drug: How Drug Are Tested, Formulated, Produced and Regulated...
Aditi Mudgal , Swapnil kale , Srushti Atole , Shraddha Salunke , Vaibhav Pujari , Madhura Jadhav ,...
Caffeine: Friend Or Foe in Human Health?...
Elavarasi E., Puniparthi Sunitha, Yuvaraj. Ar, J. Jayadurka, Madhumitha S., K. Pooja, K. Divya, S. H...
RNA Therapeutics: Clinical Pharmacokinetic and Therapeutic Monitoring...
Mayuri Jagtap, Sakshi Bodke, Avinash Darekar, ...
Development Drug: How Drug Are Tested, Formulated, Produced and Regulated...
Aditi Mudgal , Swapnil kale , Srushti Atole , Shraddha Salunke , Vaibhav Pujari , Madhura Jadhav ,...
Caffeine: Friend Or Foe in Human Health?...
Elavarasi E., Puniparthi Sunitha, Yuvaraj. Ar, J. Jayadurka, Madhumitha S., K. Pooja, K. Divya, S. H...
RNA Therapeutics: Clinical Pharmacokinetic and Therapeutic Monitoring...
Mayuri Jagtap, Sakshi Bodke, Avinash Darekar, ...